SEC 13F Intelligence

Assenagon Asset Management S.A. / VRTX

Assenagon Asset Management S.A.’s Vertex Pharmaceuticals Inc Position

Does Assenagon Asset Management S.A. own Vertex Pharmaceuticals Inc (VRTX)? Yes — 759.6K shares worth $377M (+0.47% of its 13F portfolio) as of Q2 2026, up from 537.2K shares the prior filed quarter.

Position Value
$377M
Q2 2026
Shares
759.6K
% of Portfolio
+0.47%
Quarters Held
31
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $64MQ4 ’18Q1 ’19: $13MQ2 ’19: $2MQ3 ’19: $5MQ4 ’19: $59MQ4 ’19Q1 ’20: $183MQ2 ’20: $36MQ3 ’20: $34MQ4 ’20: $141MQ4 ’20Q1 ’21: $59MQ2 ’21: $48MQ3 ’21: $13MQ4 ’21: $71MQ4 ’21Q1 ’22: $211MQ2 ’22: $145MQ3 ’22: $192MQ4 ’22: $213,405Q4 ’22Q1 ’23: $195MQ2 ’23: $135MQ3 ’23: $70MQ4 ’23: $121MQ4 ’23Q1 ’24: $135MQ2 ’24: $45MQ3 ’24: $145MQ4 ’24: $338MQ4 ’24Q1 ’25: $101MQ2 ’25: $108MQ3 ’25: $299MQ4 ’25: $378MQ4 ’25Q1 ’26: $240MQ2 ’26: $377Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026759.6K$377M+0.47%
Q1 2026537.2K$240M+0.36%
Q4 2025832.9K$378M+0.52%
Q3 2025763.7K$299M+0.41%
Q2 2025242.8K$108M+0.16%
Q1 2025208.1K$101M+0.17%
Q4 2024839.7K$338M+0.55%
Q3 2024311.6K$145M+0.27%
Q2 202496.2K$45M+0.10%
Q1 2024323.1K$135M+0.32%
Q4 2023296.2K$121M+0.32%
Q3 2023202.2K$70M+0.22%
Q2 2023384.7K$135M+0.47%
Q1 2023618.8K$195M+0.69%
Q4 2022739.0K$213,405+0.77%
Q3 2022662.2K$192M+0.74%
Q2 2022516.0K$145M+0.54%
Q1 2022808.6K$211M+0.59%
Q4 2021322.2K$71M+0.20%
Q3 202169.5K$13M+0.04%
Q2 2021236.1K$48M+0.16%
Q1 2021273.8K$59M+0.24%
Q4 2020598.4K$141M+0.62%
Q3 2020124.3K$34M+0.19%
Q2 2020125.6K$36M+0.23%
Q1 2020767.6K$183M+1.46%
Q4 2019269.4K$59M+0.37%
Q3 201928.6K$5M+0.03%
Q2 20199.3K$2M+0.01%
Q1 201968.6K$13M+0.12%
Q4 2018383.8K$64M+0.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of VRTX.